Gene · 10481
Papers1,917
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 1,917
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Targeted Therapy for Cancers: From Ongoing Clinical Trials to FDA-Approved Drugs. | Int J Mol Sci | 2023 | 37686423 | PubTator, text mining | PubMed |
| A Digital PCR Method Based on Highly Specific Taq for Detecting Gene Editing and Mutations. | Int J Mol Sci | 2023 | 37686219 | PubTator, text mining | PubMed |
Report on the Effect of the Implementation of an Early Detection and Prevention of Cancer Program on Families at High Hereditary Risk-Concentrating on Patients Undergoing Genetic Diagnostics and Counseling in Central Poland. | Int J Mol Sci | 2023 | 37685988 | PubTator, text mining | PubMed |
| Transposable elements as tissue-specific enhancers in cancers of endodermal lineage. | Nat Commun | 2023 | 37658059 | PubTator, text mining | PubMed |
| Investigation of germline variants in Bahraini women with breast cancer using next-generation sequencing based-multigene panel. | PLoS One | 2023 | 37656691 | PubTator, text mining | PubMed |
| Prostate Cancer: Genetics, Epigenetics and the Need for Immunological Biomarkers. | Int J Mol Sci | 2023 | 37628978 | PubTator, text mining | PubMed |
| Omics Technologies Improving Breast Cancer Research and Diagnostics. | Int J Mol Sci | 2023 | 37628869 | PubTator, text mining | PubMed |
| Homeobox Gene Expression Dysregulation as Potential Diagnostic and Prognostic Biomarkers in Bladder Cancer. | Diagnostics (Basel) | 2023 | 37627900 | PubTator, text mining | PubMed |
| Differential Protein Expression Patterns of HOXA13 and HOXB13 Are Associated with Bladder Cancer Progression. | Diagnostics (Basel) | 2023 | 37627895 | PubTator, text mining | PubMed |
| Extended Adjuvant Endocrine Therapy in Early Breast Cancer Patients-Review and Perspectives. | Cancers (Basel) | 2023 | 37627218 | PubTator, text mining | PubMed |
| The anoikis-related gene signature predicts survival accurately in colon adenocarcinoma. | Sci Rep | 2023 | 37626132 | PubTator, text mining | PubMed |
| The Spectrum of Germline Nucleotide Variants in Gastric Cancer Patients in the Kyrgyz Republic. | Curr Issues Mol Biol | 2023 | 37623222 | PubTator, text mining | PubMed |
| A biallelic multiple nucleotide length polymorphism explains functional causality at 5p15.33 prostate cancer risk locus. | Nat Commun | 2023 | 37612286 | PubTator, text mining | PubMed |
| SARS-CoV-2 infection severity and mortality is modulated by repeat-mediated regulation of alternative splicing. | Microbiol Spectr | 2023 | 37604131 | PubTator, text mining | PubMed |
| Cobind: quantitative analysis of the genomic overlaps. | Bioinform Adv | 2023 | 37600846 | PubTator, text mining | PubMed |
| Improved Prostate-Specific Membrane Antigen (PSMA) Stimulation Using a Super Additive Effect of Dutasteride and Lovastatin In Vitro. | Int J Mol Sci | 2023 | 37569712 | PubTator, text mining | PubMed |
| Advancements in MRI-Based Radiomics and Artificial Intelligence for Prostate Cancer: A Comprehensive Review and Future Prospects. | Cancers (Basel) | 2023 | 37568655 | PubTator, text mining | PubMed |
A Randomized Trial Comparing the Effectiveness of Pre-test Genetic Counseling Using an Artificial Intelligence Automated Chatbot and Traditional In-person Genetic Counseling in Women Newly Diagnosed with Breast Cancer. | Ann Surg Oncol | 2023 | 37567976 | PubTator, text mining | PubMed |
| Racial disparity in the genomics of precision oncology of prostate cancer. | Cancer Rep (Hoboken) | 2023 | 37565547 | PubTator, text mining | PubMed |
| An unbiased seed-based RNAi selection screen identifies small RNAs that inhibit androgen signaling and prostate cancer cell growth. | Mol Ther Nucleic Acids | 2023 | 37554515 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10481/papers?page=11